Influenza Vaccine
Universal influenza immunization is cost-effective in children 6 - 23 months old
Published in Medical Letter on the CDC and FDA, February 19th, 2006
Researchers in the United States conducted a study "to calculate the costs of influenza hospitalization at a tertiary care children's hospital as the basis of a cost-benefit analysis of the new influenza vaccine recommendation for children age 6 to 23 months."
"We reviewed the medical records of all patients admitted to Children's Memorial Hospital (CMH) in 2002 diagnosed with influenza. Total hospital costs were obtained from the Business Development Office. Thirty-five charts were analyzed," said Jennifer L. Hall and Ben Z. Katz at Northwestern University.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Therapy
Report presents useful techniques for evaluating cancer control efforts - Influenza Vaccine
Nucleoprotein vaccine protects against multiple influenza subtypes - Listeriosis Outbreak
Multistate U.S. outbreak of listeriosis is linked to turkey deli meat - Pneumonia
Study examined trends in hospitalization for pneumonia among elderly in U.S. - Smallpox Vaccine
Study characterized vaccinia virus antigens recognized by vaccinia immune globulin - Addiction Medicine
Review examines future advances in addiction treatment - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
